riluzole has been researched along with Dyspnea in 2 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Dyspnea: Difficult or labored breathing.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lau, FS | 1 |
| Brennan, FP | 1 |
| Gardiner, MD | 1 |
| Scott, K | 1 |
| Shannon, R | 1 |
| Roche-Green, A | 1 |
| Searcy, R | 1 |
| Woolyhand, G | 1 |
| Meeks, G | 1 |
| Schuh, M | 1 |
2 other studies available for riluzole and Dyspnea
| Article | Year |
|---|---|
Multidisciplinary management of motor neurone disease.
Topics: Dyspnea; Humans; Interdisciplinary Communication; Motor Neuron Disease; Muscle Spasticity; Neuroprot | 2018 |
Pharmacologic Management Strategies in ALS #301.
Topics: Amyotrophic Lateral Sclerosis; Depression; Dyspnea; Guidelines as Topic; Humans; Muscle Spasticity; | 2016 |